Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Cognitive Pharmaceuticals was established in 2001 based on a proprietary platform technology developed at the University of Toledo, College of Pharmacy, and in April 2003 was registered in Michigan as a for-profit organization [www.medc.michigan.org] [www.michbio.org]. Emphasis is on products with significant return on investment in expanding markets with unmet needs. A potential treatment of Alzheimer’s disease is presently in development. The mechanism of action of CDD-0102 differs from marketed drugs, targeting both the symptoms – progressive loss of memory and cognitive function – and the underlying cause of the disease – accumulation of amyloid plaque and neurofibrillary ( www.cognitivepharma.com )
Cognitive Pharmaceuticals , Ltd.
6722 Spring Creek Lane
Plymouth, Michigan 48170
USA
Tel: (248) 437-5129
Fax: (248) 437-7656